Gennao Bio nabs $40M for its gene monoclonal antibody platform
Gennao Bio has closed $40 million in financing to support the advancement of its proprietary gene monoclonal antibody platform and the development of targeted nucleic acid therapeutic product candidates for the treatment of cancer and rare monogenic skeletal muscle diseases. Read More
Flagship Pioneering unveils eRNA platform from Laronde
Flagship Pioneering unveiled its Laronde platform for the development of endless RNA (eRNA), a novel, engineered form of RNA that can be programmed to express therapeutic proteins inside the body. The company has initially committed $50 million to support the development of the platform and initial pipeline medicines. Read More
Twist announces Q2 financial results
Twist Bioscience announced that revenues grew in the company's second quarter of fiscal 2021, although the firm's net loss also grew. Read More
Pfizer, BioNTech initiate rolling submission of BLA for COVID-19 vaccine
Pfizer and BioNTech announced on Friday that they have started a biologics license application (BLA) with the U.S. Food and Drug Administration for approval of their messenger RNA vaccine to prevent COVID-19 in individuals ages 16 years and older. Read More
GSK, Vir start EMA rolling review for anti-SARS-CoV-2 antibody
GlaxoSmithKline (GSK) and Vir Biotechnology have announced that the European Medicines Agency (EMA) has started a rolling review of data on sotrovimab, an investigational dual-action SARS-CoV-2 monoclonal antibody. Read More
Evotec, BMS debut program to speed academic translational research
Evotec announced on May 6 a new program that aims to accelerate translational research from the U.K.'s academic life science ecosystem in collaboration with Bristol-Myers Squibb (BMS). Read More
WuXi makes strategic acquisitions to increase biologics manufacturing
WuXi Biologics has acquired manufacturing facilities from Bayer in Germany and from Pfizer in China. The company has also acquired CMAB Biopharma, a biologics contract development and manufacturing organization in China. Read More
CRISPR Therapeutics, Nkarta partner on gene edited cancer therapies
CRISPR Therapeutics has established a strategic partnership with Nkarta to research, develop, and commercialize CRISPR/Cas9 gene edited cell therapies for cancer. Read More
Moderna booster produces antibodies against SARS-CoV-2 variants
Moderna announced that initial results from a phase II study suggest a single booster dose of its messenger RNA (mRNA) vaccine candidates mRNA-1273 or mRNA-1273.351 given to previously vaccinated individuals increased neutralizing antibody titer responses against SARS-CoV-2 and two variants. Read More
Altasciences acquires Calvert Laboratories
Altasciences announced it has acquired Calvert Laboratories, a contract research organization with operations in Pennsylvania and North Carolina. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
